JP2013504751A - 血管疾患を診断および評価するためのポリペプチドマーカー - Google Patents

血管疾患を診断および評価するためのポリペプチドマーカー Download PDF

Info

Publication number
JP2013504751A
JP2013504751A JP2012528391A JP2012528391A JP2013504751A JP 2013504751 A JP2013504751 A JP 2013504751A JP 2012528391 A JP2012528391 A JP 2012528391A JP 2012528391 A JP2012528391 A JP 2012528391A JP 2013504751 A JP2013504751 A JP 2013504751A
Authority
JP
Japan
Prior art keywords
markers
polypeptide
sample
amplitude
marker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012528391A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013504751A5 (enExample
Inventor
ミシャク、ハラルド
Original Assignee
モザイクス ダイアグノスティクス アンド セラピューティクス アーゲー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by モザイクス ダイアグノスティクス アンド セラピューティクス アーゲー filed Critical モザイクス ダイアグノスティクス アンド セラピューティクス アーゲー
Publication of JP2013504751A publication Critical patent/JP2013504751A/ja
Publication of JP2013504751A5 publication Critical patent/JP2013504751A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848Methods of protein analysis involving mass spectrometry
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/32Cardiovascular disorders

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biophysics (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2012528391A 2009-09-14 2010-09-14 血管疾患を診断および評価するためのポリペプチドマーカー Pending JP2013504751A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09170190.4 2009-09-14
EP09170190 2009-09-14
PCT/EP2010/063475 WO2011029954A2 (de) 2009-09-14 2010-09-14 Polypeptidmarker zur diagnostik und beurteilung vaskulärer erkrankungen

Publications (2)

Publication Number Publication Date
JP2013504751A true JP2013504751A (ja) 2013-02-07
JP2013504751A5 JP2013504751A5 (enExample) 2013-10-24

Family

ID=43301867

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012528391A Pending JP2013504751A (ja) 2009-09-14 2010-09-14 血管疾患を診断および評価するためのポリペプチドマーカー

Country Status (4)

Country Link
US (2) US20120241321A1 (enExample)
EP (1) EP2478377A2 (enExample)
JP (1) JP2013504751A (enExample)
WO (1) WO2011029954A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008223791B2 (en) * 2007-03-07 2013-10-03 Mosaiques Diagnostics And Therapeutics Ag Method for the standardization of the concentration of analytes in a urine sample
EP1972940A1 (de) * 2007-03-14 2008-09-24 mosaiques diagnostics and therapeutics AG Verfahren und Marker zur Diagnose von Nierenerkrankungen
US9404932B2 (en) * 2007-11-05 2016-08-02 Nordic Bioscience A/S Pathology biomarker assay
US20120037507A9 (en) * 2008-03-19 2012-02-16 Harald Mischak Method and marker for diagnosis of tubular kidney damage and illnesses
WO2010031822A1 (de) * 2008-09-17 2010-03-25 Mosaiques Diagnostics And Therapeutics Ag Nierenzellkarzinom
WO2013150132A2 (de) * 2012-04-05 2013-10-10 Mosaiques Diagnostics And Therapeutics Ag Polypeptidmarker zur diagnostik und beurteilung von schlaganfällen

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009521670A (ja) * 2005-11-30 2009-06-04 モザイク・ダイアグノステイツクス・アンド・テラピユーテイツクス・アー・ゲー 血管疾患の診断および評価のためのポリペプチドマーカー

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1707164B1 (en) 2000-03-30 2009-11-18 Orde Levinson Urine funnelling trumpet
DE10021737C2 (de) 2000-05-04 2002-10-17 Hermann Haller Verfahren und Vorrichtung zur qualitativen und/oder quantitativen Bestimmung eines Protein- und/oder Peptidmusters einer Flüssigkeitsprobe, die dem menschlichen oder tierischen Körper entnommen wird
EP2479284B1 (en) * 2006-07-13 2017-09-20 University of Iowa Research Foundation Methods and reagents for treatment and diagnosis of vascular disorders and age-related macular degeneration

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009521670A (ja) * 2005-11-30 2009-06-04 モザイク・ダイアグノステイツクス・アンド・テラピユーテイツクス・アー・ゲー 血管疾患の診断および評価のためのポリペプチドマーカー

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN5012018630; ZIMMERLI L U: 'URINARY PROTEOMIC BIOMARKERS ON CORONARY ARTERY DISEASE' MOLECULAR & CELLULAR PROTEINS VOL. 7, NO. 2, 200802, PAGES 290-298 *

Also Published As

Publication number Publication date
WO2011029954A3 (de) 2011-06-16
EP2478377A2 (de) 2012-07-25
US20150018246A1 (en) 2015-01-15
WO2011029954A2 (de) 2011-03-17
US20120241321A1 (en) 2012-09-27

Similar Documents

Publication Publication Date Title
JP2013504751A (ja) 血管疾患を診断および評価するためのポリペプチドマーカー
US20150122650A1 (en) Polypeptide markers for the diagnosis of bladder cancer
US20140073057A1 (en) Process and markers for the diagnosis of kidney diseases
US20110036717A1 (en) Method and marker for diagnosis of tubular kidney damage and illness
US20120118737A1 (en) Method And Markers For Diagnosing Acute Renal Failure
US20100248378A1 (en) Method and marker for diagnosing diabetes mellitus
US20100062537A1 (en) Polypeptide Markers for the Diagnosis and Evaluation of Pelvi-Ureteric Junction Obstruction (PUJO)
JP5165580B2 (ja) 血管疾患の診断および評価のためのポリペプチドマーカー
US20150126405A1 (en) Polypeptide markers for the early recognition of the rejection of transplanted kidneys
JP5550021B2 (ja) 血液試料を用いて心筋虚血状態を評価する方法
MX2008006724A (en) Polypeptide marker for the diagnosis and evaluation of vascular diseases
RU2405159C2 (ru) Полипептидный маркер для диагноза артериосклероза
JP5147684B2 (ja) アルツハイマー病の診断のためのポリペプチドマーカー
CN101317095A (zh) 用于诊断和评价血管病的多肽标志物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130904

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130904

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20140327

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20141118

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20150212

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20150707